Pulmatrix Inc (PULM) Stock Analysis

Pulmatrix Inc (PULM) is a publicly traded company in the HEALTHCARE sector. It trades at $1.33, carries a market capitalization of $5.08M. This page summarizes the public market data, fundamentals, and frequently asked questions for PULM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.33
• Market Cap: $5.08M
• EPS: $-1.23
• 52-Week High: $9.23
• 52-Week Low: $1.16

Market Sentiment

Pulmatrix Inc currently has a Bullish sentiment score of 0.19.

About Pulmatrix Inc

Pulmatrix, Inc. is a clinical-stage biopharmaceutical company headquartered in Lexington, Massachusetts, dedicated to the discovery and development of innovative inhaled therapies for respiratory diseases and other serious conditions characterized by unmet medical needs. By harnessing its proprietary technologies and extensive expertise in inhalation drug delivery, Pulmatrix is actively advancing a pipeline of transformative treatments that aim to significantly enhance patient outcomes and ov...

GNG Research Analysis

GNG Research scores Pulmatrix Inc (PULM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PULM.

Frequently Asked Questions

Does PULM pay dividends?

Pulmatrix Inc (PULM) does not currently pay a regular dividend.

What is PULM's market cap?

Pulmatrix Inc (PULM) has a market capitalization of $5.08M with a current stock price of $1.33.